AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Charles River Laboratories to Present at Upcoming Investor Conferences

November 11, 2019

WILMINGTON, Mass.--(BUSINESS WIRE)--Nov 11, 2019--

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including:

Management will present an overview of Charles River’s strategic focus and business developments.

A live webcast of each event will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each event and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191111005045/en/

CONTACT: Investor Relations Contact:

Todd Spencer

Corporate Vice President, Investor Relations

781.222.6455

todd.spencer@crl.com

KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA ARIZONA MASSACHUSETTS

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH MEDICAL DEVICES HEALTH PHARMACEUTICAL

SOURCE: Charles River Laboratories International, Inc.

Copyright Business Wire 2019.

PUB: 11/11/2019 08:30 AM/DISC: 11/11/2019 08:30 AM

http://www.businesswire.com/news/home/20191111005045/en